Gilead names remdesivir price
The treatment will cost $3,120 for a five-day treatment course for a patient with private insurance in the U.S.
Drug Pricing
Appeals court strikes down the rule requiring list prices in drug ads, again
A previous judge ruled that HHS did not have the authority to issue the rule.
COVID-19 vaccine collides with drug price fervor
Three pharma companies launch the first human clinical trials of experimental COVID-19 drugs and vaccines.
Pharmacies are getting a bad name when price myopia is the real culprit
A recent New York Times article took aim at pharmacies, but the major problem going unresolved is price myopia.
Democratic debate recap: Health insurance and drug prices get the spotlight
The last Democratic debate before the Iowa caucuses focused more on foreign policy than healthcare.
Appeals court considers HHS’ TV drug price disclosure rule
The appeals court questioned HHS’ authority and whether the list price would only confuse consumers.
Why the dance between manufacturers and PBMs continues
States have targeted co-pay accumulators, claiming they run up costs for patients who need expensive specialty drugs. Here’s why their legislation hasn’t yet had the intended impact.
Prices to increase on hundreds of drugs in 2020
Drug companies kicked off the new year by announcing price hikes.
Watch: Martin Sheen rants about drug prices in SingleCare ad
“That’s larceny!” Sheen exclaims upon seeing the cost of his medicine.
It’s time to push back on drug price legislation
Sander Flaum wants pharma to push back on pricing legislation.
